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- Addiction is a disorder of maladaptive learning and memory. 
- Different limbic corticostriatal regions support drug-associated memories. 
- Disrupting drug-memory reconsolidation may provide a new addiction treatment. 
- Regional manipulation makes specific aspects of drug memory tractable targets. 
 
ABSTRACT 
Addiction can be conceptualised as a disorder of maladaptive learning and memory. Therefore, 
maladaptive drug memories supporting drug-seeking and relapse behaviours may present novel 
treatment targets for therapeutic approaches based upon reconsolidation-blockade. It is known that 
different structures within the limbic corticostriatal system contribute differentially to different types 
of maladaptive drug memories, including pavlovian associations between environmental cues and 
contexts with the drug high, and instrumental memories underlying drug-seeking. Here, we review 
the mechanisms underlying drug memory reconsolidation in the amygdala, striatum, and 
hippocampus, noting similarities and differences, and opportunities for future research.  
 
INTRODUCTION  
Addiction, a complex disease [1], can be conceptualised as a disorder of maladaptive memory [2,3] 
for which preventing relapse is the greatest challenge. Drug-associated memories might therefore 
provide a novel anti-relapse treatment target [4-6]. Disrupting drug-associated memories was not 
considered feasible until memory reconsolidation was rediscovered [7]. The prospect of modifying 
well-established memories raised the possibility that disrupting the memories driving relapse could 
be a novel pro-abstinence therapy. This view was supported by early studies showing that 
pharmacological agents ranging from protein synthesis and protein kinase inhibitors [8,9] to β-
adrenergic receptor antagonists [10,11] reduced subsequent drug-seeking in rodents, if administered 
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while the drug memory was ‘reactivated’ and unstable. This instability is usually achieved by briefly 
presenting discrete or contextual drug-associated conditioned stimuli (CSs) in the absence of drug 
or, less frequently, drug in the absence of associated CSs.   
 
Any memory-modifying pharmacological treatment would need to be administered systemically in 
patients. However, understanding the neural mechanisms that support drug-associated memories 
remains important. We have previously reviewed how initially neutral environmental CSs (such as 
discrete cues, people, drug paraphernalia, contextual cues) become associated with drug highs in a 
pavlovian manner and subsequently increase drug-seeking [4]. Drug-seeking and drug-taking 
themselves are supported by instrumental memories that are initially goal-directed, associating the 
drug-seeking action with the drug-procurement outcome, but ultimately become habitual and driven 
by pavlovian CSs [12]. These memories are supported by different structures within the limbic-
corticostriatal circuitry. Pavlovian CS-drug memories, particularly for discrete CSs, are represented 
within the amygdala, while the hippocampus is required for representing drug-associated contexts. 
Goal-directed and habitual memories are supported by different striatal regions, with a ventral-to-
dorsal striatal shift as drug-seeking becomes habitual [12]. While all these regions contribute to 
drug-seeking behaviour and relapse, it cannot be assumed that the same plasticity mechanisms 
underlie memory persistence in all regions. We review the molecular and neurochemical 
mechanisms underlying drug memory reconsolidation in three key regions of the limbic 
corticostriatal circuitry: the amygdala, striatum, and hippocampus (Figure 1). 
 
TARGETING THE RECONSOLIDATION OF PAVLOVIAN CUE-DRUG MEMORIES 
IN THE AMYGDALA  
The amygdala is essential for associating environmental CSs with the affective value of the drug 
unconditioned stimulus (US). The basolateral (BLA) and central amygdala (CeA) differ in their 
representation of drug-associated CSs and may be differentially required for the reconsolidation of 
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memories induced by CS-based and US-based reactivation procedures [13]. As CS-drug memories 
are potent precipitators of relapse, both the BLA and CeA are logical targets for memory 
reconsolidation blockade [14].  
 
The CeA appears engaged by US-based reactivation [15]. US-based alcohol memory reactivation 
leads to increased phosphorylation of S6 kinase (S6K), a critical component of the mammalian target 
of rapamycin (mTOR) pathway controlling mRNA translation (for review, see [16]) in the CeA, but 
not BLA [15]. Expression of excitatory transmission proteins, including Arc, PSD-95 and the GluA1 
subunit of AMPA receptors is also increased. These increases appear necessary for reconsolidation 
in the CeA, as preventing S6K phosphorylation via upstream mTOR inhibition, concurrent with 
alcohol memory reactivation, prevented subsequent reinstatement of alcohol-seeking. Interestingly, 
this effect was specific to alcohol, not affecting sucrose memories. This suggests alcohol may recruit 
intracellular mechanisms, distinguishable from natural rewards, which may be specifically targeted.  
 
More often reconsolidation-based interventions focus on the BLA, which represents the association 
between pavlovian CSs and specific outcomes [17]. As for US-based reactivation in the CeA, 
preventing mRNA translation in the BLA, concurrent with CS-based reactivation, disrupted drug 
memory reconsolidation [18]. Targeting intracellular pathways upstream of mRNA translation 
produces similar effects. The activation of protein kinases – or suppression of protein phosphatases 
– regulates mRNA translation, and several protein kinases in the BLA are necessary for CS-drug 
memory reconsolidation. Inhibiting protein kinase A (PKA) in the BLA during CS-based memory 
reactivation prevented both subsequent CS-induced and context-induced reinstatement [19-21], 
though not drug-primed reinstatement [19]. At reactivation, activating Exchange Protein Activated 
by cAMP (EPac) with 8-pCPT-cAMP disrupted subsequent CS-induced reinstatement of cocaine 
seeking [22]. Furthermore, while increasing PKA-mediated signalling via 6-Bnz-cAMP did not enhance 
CS-drug memory reconsolidation [22], co-administration of 6-Bnz-cAMP with 8-CPT at reactivation 
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rescued the deficit produced by activating EPac, suggesting antagonist feedback between the PKA 
and EPac pathways. Similarly, inhibiting another protein kinase, calcium-calmodulin-dependent kinase 
II (CaMKII), attenuated subsequent cue-induced reinstatement [23]. However, inhibiting CaMKII 
during CS-drug memory reactivation did not reduce subsequent context-induced cocaine seeking 
[20]. Overactivation of the calcium-triggered phosphatase calcineurin during reactivation inhibited 
both subsequent CS- and context-induced reinstatement of cocaine-seeking [24].  
 
At the level of immediate early genes (IEGs), zif268 has been repeatedly implicated in drug memory 
reconsolidation. Knockdown of zif268 in the BLA before a CS-based reactivation decreased the 
acquisition of new, flexible cocaine-seeking [25] and cue-induced reinstatement of subsequent 
cocaine-seeking [26]. Upstream of Zif268 expression, antagonism of NMDARs in the BLA prior to 
memory reactivation not only prevented the acquisition of flexible cocaine-seeking, but also reduced 
the expression of Zif268 [27].  
 
Taken together, the BLA and CeA seem differentially recruited by the use of context, discrete CSs 
and drug USs to reactivate the drug memory. Notably, the involvement of these regions in drug-
induced habitual responding changes with extended drug exposure. The BLA projects densely to the 
nucleus accumbens core, which itself projects to more dorsal striatal regions. With limited drug self-
administration, the pharmacological uncoupling of the BLA with the dorsolateral striatum reduced 
cocaine-seeking, whereas CeA manipulations had no effect until drug experience was extensive [28]. 
Therefore, we speculate that there may also be a BLA-to-CeA shift as drug experience becomes 
more extensive, and a consequent shift in the efficacy of CS-based and US-based reactivation 




TARGETING THE RECONSOLIDATION OF PAVLOVIAN CUE-DRUG MEMORIES 
IN THE VENTRAL STRIATUM  
The striatum consists of ventral (nucleus accumbens core, NAcbC, and shell, NAcbSh) and dorsal 
substructures. The BLA projects densely to the NAcbC, and both the BLA and NAcbC are required 
for pavlovian CSs to influence instrumental responding [29]. As for the BLA, expression of zif268 
increases in the NAcbC following cocaine CS exposure [30], and phosphorylation of specific 
proteins in the BLA and NAcbC is altered following CS-based drug memory reactivation [31]. 
 
However, the NAcbC supports different aspects of the CS-drug memory to the BLA. Unlike the 
BLA [25], the reconsolidation of CS-drug memories supporting flexible cocaine-seeking does not 
require Zif268 in the NAcbC [32], even though NAcbC-BLA interactions are necessary for drug-
associated conditioned reinforcers to support flexible cocaine-seeking [33]. Similarly, inhibiting ERK 
in the BLA, but not NAcbC, at reactivation impairs subsequent context-induced reinstatement of 
cocaine-seeking [34], though manipulations targeting the NAcbC consistently disrupt the 
reconsolidation of drug-conditioned place preference (CPP) memories [8,9,32, 35-38] and memories 
for approach to drug assessed using the runway procedure [39]. The NAcbC may be an important 
target for disrupting reconsolidation of general motivational properties of pavlovian CSs, alongside 
disruption of their sensory-specific properties by targeting the BLA. 
 
TARGETING THE RECONSOLIDATION OF CONTEXT-DRUG MEMORIES IN THE 
HIPPOCAMPUS  
The dorsal hippocampus (DH) is necessary for the representation of contextual information, and 
inactivation of the DH acutely impairs the context-induced reinstatement of drug-seeking [40]. The 
hippocampus has a well-established role in context-drug memory reconsolidation as measured by 
CPP [41-43]. For instrumental drug-seeking behaviour, the requirement for the hippocampus 
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appears less straightforward. Inactivation of the DH with tetrodotoxin [44] or inhibition of GluN2A-
containing NMDARs or Src family kinases [45] prevents context-induced reinstatement in a 
reactivation-dependent manner. However, inhibiting protein synthesis with anisomycin does not 
[44]. Instead, protein synthesis inhibition in the BLA, coupled with contralateral inhibition of the DH 
in a ‘disconnection’ procedure, persistently reduced context-induced reinstatement [21]. This likely 
indicates that although the DH is required to represent the contextual aspects of the context-drug 
memory, it is the BLA that stores the context-drug engram. 
 
TARGETING THE RECONSOLIDATION OF INSTRUMENTAL MEMORIES 
UNDERLYING DRUG-SEEKING IN THE DORSAL STRIATUM 
Drug-seeking and taking rely on instrumental memories. Instrumental learning recruits the dorsal 
striatum, with response-outcome (goal-directed) associations depending on the dorsomedial 
striatum (DMS), and stimulus-response (habitual) associations on the dorsolateral striatum (DLS) 
[46-49]. Originally, instrumental memories were thought not to reconsolidate [50]. However, this 
may have been due to unsuccessful memory destabilisation. Later studies disrupted instrumental 
memory reconsolidation by NMDAR antagonism with a change in reinforcement contingency at 
reactivation [51,52], preventing subsequent stress-induced, though not CS-induced, relapse to 
cocaine-seeking [53]. While the NMDAR antagonist was administered systematically, we speculate 
that it may have affected dorsal striatal regions. This remains to be tested with local injections, or by 
assessing the effects of NMDAR antagonism on local reconsolidation markers such as Zif268 
expression. However, it notable that knocking down zif268 in the posterior DLS during reactivation 
of a stimulus-response memory only transiently reduced habit-like behaviour on a T-maze task [54]. 
Whether this indicates that other IEGs are important for supporting the reconsolidation of 
instrumental memories, or other regions compensate for the loss of the memory in the posterior 





Addiction is a disorder of learning and memory that presents many different psychological targets for 
disruption, including pavlovian and instrumental memories, and their interactions. Different regions 
support distinct aspects of drug-related memories, from the BLA supporting sensory-specific 
memories of drug CSs, the CeA contributing to US-based reactivation, the DH supporting 
contextual information, and the striatum supporting instrumental memories (Figure 1). Though there 
are common principles regarding the molecular mechanisms underlying reconsolidation between 
these different regions – e.g. the recruitment of protein kinases and IEGs – it cannot be assumed 
that the mechanisms are identical between all structures. This may be particularly true for the 
relatively understudied (in the reconsolidation literature) GABAergic dorsal striatum. Further 
characterisation of reconsolidation mechanisms across brain structures would not only provide 
insight into the degree of conservation of plasticity mechanisms, but may also allow for systemic 
treatments to be used to target specific brain regions where a receptor or molecular pathway is 
uniquely associated with reconsolidation. 
This review focused upon key structures within the limbic-corticostriatal circuitry, as they relate 
when drug-seeking is not yet compulsive. However, the progressively habitual and compulsive nature 
of drug-seeking in addiction leads to changes in the reliance on different structures within the limbic-
corticostriatal circuitry [12]. While it is known that systems-level reconsolidation occurs between 
the hippocampus and the cortex [55,56], it remains unknown whether similar systems-level 
reconsolidation occurs, for example, between the BLA and CeA following extensive drug experience 
[28], or between different striatal regions as drug-seeking transitions from goal-directed to habitual. 
Coupled with potential differences in the molecular pathways supporting reconsolidation in different 
brain regions, changes in dependence on different parts of the limbic-corticostriatal circuitry could 
account for apparently dynamic boundary conditions. We suggest that in addition to characterising 
the molecular mechanisms of reconsolidation in different brain structures, research should focus on 
understanding how the memories that form the targets for reconsolidation-blockade move with 
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FIGURE LEGEND 
Figure 1. (a) Sagittal section of the rat brain, with key locations implicated in drug memory 
reconsolidation highlighted. (b) Schematic of major connections between brain regions implicated in 
drug memory reconsolidation, indicating the aspect of the drug memory encoded by each region. 
The type of memory reactivation protocol that appears effective at recruiting each region is noted in 
brackets. Abbreviations: Amy, amygdala; DH, dorsal hippocampus; DS, dorsal striatum; NAcb, 
nucleus accumbens. 

